Antiviral Activity of Catechin against Dengue Virus Infection

Dengue virus (DENV) is the cause of dengue fever, infecting 390 million people worldwide per year. It is transmitted to humans through the bites of mosquitoes and could potentially develop severe symptoms. In spite of the rising social and economic impact inflicted by the disease on the global population, a conspicuous lack of efficacious therapeutics against DENV still persists. In this study, catechin, a natural polyphenol compound, was evaluated as a DENV infection inhibitor in vitro. Through time-course studies, catechin was shown to inhibit a post-entry stage of the DENV replication cycle. Further investigation revealed its role in affecting viral protein translation. Catechin inhibited the replication of all four DENV serotypes and chikungunya virus (CHIKV). Together, these results demonstrate the ability of catechin to inhibit DENV replication, hinting at its potential to be used as a starting scaffold for further development of antivirals against DENV infection.

[1]  J. Chu,et al.  Lichen-Derived Diffractaic Acid Inhibited Dengue Virus Replication in a Cell-Based System , 2023, Molecules.

[2]  Daniel J. Deredge,et al.  Current Trends and Limitations in Dengue Antiviral Research , 2021, Tropical medicine and infectious disease.

[3]  A. Emwas,et al.  Antiviral activities of flavonoids , 2021, Biomedicine & Pharmacotherapy.

[4]  J. Chu,et al.  Betulinic Acid exhibits antiviral effects against dengue virus infection. , 2020, Antiviral research.

[5]  M. Shimojima,et al.  Several catechins and flavonols from green tea inhibit severe fever with thrombocytopenia syndrome virus infection in vitro. , 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[6]  Jianan Huang,et al.  Role and mechanism of catechin in skeletal muscle cell differentiation. , 2019, The Journal of nutritional biochemistry.

[7]  S. Robledo,et al.  In vitro and in silico anti-dengue activity of compounds obtained from Psidium guajava through bioprospecting , 2019, BMC Complementary and Alternative Medicine.

[8]  J. Chu,et al.  Antiviral activity of ST081006 against the Dengue virus. , 2019, Antiviral research.

[9]  J. Chu,et al.  Antiviral activity of pinocembrin against Zika virus replication. , 2019, Antiviral research.

[10]  Chao Liu,et al.  Catechin attenuates TNF-α induced inflammatory response via AMPK-SIRT1 pathway in 3T3-L1 adipocytes , 2019, PloS one.

[11]  J. Chu,et al.  Drug repurposing of quinine as antiviral against dengue virus infection. , 2018, Virus research.

[12]  C. Buerano,et al.  Inhibitory effect of the green tea molecule EGCG against dengue virus infection , 2018, Archives of Virology.

[13]  J. Saiz,et al.  Antiviral Properties of the Natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus , 2017, Front. Microbiol..

[14]  H. Yamada,et al.  Anti-influenza Virus Effects of Catechins: A Molecular and Clinical Review. , 2016, Current medicinal chemistry.

[15]  A. Vibhuti,et al.  Molecular docking NS4B of DENV 1-4 with known bioactive phyto-chemicals , 2016, Bioinformation.

[16]  Cameron P. Simmons,et al.  Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. Chu,et al.  Antiviral activity of silymarin against chikungunya virus , 2015, Scientific Reports.

[18]  J. Connolly,et al.  Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial. , 2014, The Lancet. Infectious diseases.

[19]  A. Yueh,et al.  Baicalin, a metabolite of baicalein with antiviral activity against dengue virus , 2014, Scientific Reports.

[20]  A. Gliszczyńska-Świgło,et al.  The influence of stereochemistry on the antioxidant properties of catechin epimers , 2012, European Food Research and Technology.

[21]  C. T. Tam,et al.  Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  Niranjan Nagarajan,et al.  A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients , 2012, The Journal of infectious diseases.

[23]  Xinwen Chen,et al.  (−)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus , 2012, Archives of Virology.

[24]  P. Wong,et al.  Antiviral activity of four types of bioflavonoid against dengue virus type-2 , 2011, Virology Journal.

[25]  M. Manns,et al.  The green tea polyphenol, epigallocatechin‐3‐gallate, inhibits hepatitis C virus entry , 2011, Hepatology.

[26]  P. Roach,et al.  Extraction and isolation of catechins from tea. , 2010, Journal of separation science.

[27]  J. Farrar,et al.  A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults , 2010, PLoS neglected tropical diseases.

[28]  M. Albert,et al.  Biology and pathogenesis of chikungunya virus , 2010, Nature Reviews Microbiology.

[29]  H. Ho,et al.  Antiviral effect of epigallocatechin gallate on enterovirus 71. , 2009, Journal of agricultural and food chemistry.

[30]  B. Seong,et al.  Antiviral effect of catechins in green tea on influenza virus. , 2005, Antiviral research.

[31]  R. Tesh,et al.  Transovarial transmission of dengue viruses by mosquitoes: Aedes albopictus and Aedes aegypti. , 1983, The American journal of tropical medicine and hygiene.

[32]  S. Halstead,et al.  Dengue , 1872, The Lancet.

[33]  B. Schnierle,et al.  The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection. , 2015, Antiviral research.

[34]  B. Seong,et al.  Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens. , 2012, Poultry science.

[35]  A. Tokunaga,et al.  A Summary of , 2011 .